Stock listing
NASDAQ:ONCO Onconetix, Inc. Stock
Home listing (NASDAQ) of Onconetix, Inc.
Follow Onconetix, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ONCO
$2.89 USD -0.26 (-8.3%)
Close on Nov 20, 2026
- Day range
- $2.85 – $3.31 USDNov 20, 2026
- Volume
- 42,902 sharesNov 20, 2026
- Market cap
- $2.37M USDAt the close on Nov 20, 2026 · price × 820,611 shares outstanding
- 52-week range
- $0.342 – $161.00 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $484,109 USDMedian day 60,690 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ONCO · Home | $2.89 USD | -0.26 (-8.3%) | 42,902 | $3.31 | $3.31 | $2.85 | $3.15 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ONCO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.89 | -0.26 | -8.3% | $3.31 | $3.31 | $2.85 | 42,902 | |
| $3.15 | +0.15 | +5.0% | $3.12 | $3.22 | $3.04 | 63,759 | |
| $3.00 | +0.09 | +3.1% | $2.96 | $3.01 | $2.854 | 30,255 | |
| $2.91 | -0.30 | -9.3% | $3.21 | $3.21 | $2.76 | 62,029 | |
| $3.21 | +0.18 | +5.9% | $3.09 | $3.35 | $2.91 | 70,294 | |
| $3.03 | -0.73 | -19.4% | $3.58 | $3.58 | $2.94 | 90,432 | |
| $3.76 | +0.29 | +8.4% | $3.49 | $3.80 | $3.45 | 73,100 | |
| $3.47 | -0.11 | -3.1% | $3.38 | $3.79 | $3.15 | 217,400 | |
| $3.58 | -3.37 | -48.5% | $7.10 | $7.10 | $3.34 | 740,800 | |
| $6.95 | +1.46 | +26.6% | $5.68 | $7.82 | $5.618 | 763,000 | |
| $5.49 | -1.09 | -16.6% | $6.35 | $6.40 | $5.45 | 110,620 | |
| $6.58 | +0.89 | +15.6% | $5.51 | $6.69 | $5.51 | 108,480 | |
| $5.69 | +0.26 | +4.8% | $5.43 | $5.70 | $5.15 | 63,850 | |
| $5.43 | +4.869 | +867.9% | $5.38 | $5.63 | $5.01 | 66,010 | |
| $0.561 | -0.025 | -4.3% | $0.543 | $0.585 | $0.521 | 119,000 | |
| $0.586 | -0.012 | -2.0% | $0.623 | $0.647 | $0.551 | 691,100 | |
| $0.598 | +0.123 | +25.9% | $0.508 | $0.678 | $0.481 | 4,522,470 | |
| $0.475 | +0.076 | +19.0% | $0.35 | $0.481 | $0.342 | 251,550 | |
| $0.399 | -0.019 | -4.5% | $0.41 | $0.431 | $0.393 | 82,990 | |
| $0.418 | +0.011 | +2.7% | $0.427 | $0.43 | $0.40 | 56,580 | |
| $0.407 | -0.028 | -6.4% | $0.455 | $0.455 | $0.40 | 55,470 | |
| $0.435 | +0.029 | +7.1% | $0.43 | $0.463 | $0.412 | 68,920 | |
| $0.406 | -0.024 | -5.6% | $0.429 | $0.429 | $0.38 | 32,730 | |
| $0.43 | -0.049 | -10.2% | $0.483 | $0.496 | $0.422 | 36,590 | |
| $0.479 | -0.069 | -12.6% | $0.522 | $0.53 | $0.463 | 63,740 | |
| $0.548 | 0.00 | 0.0% | $0.54 | $0.554 | $0.533 | 15,990 | |
| $0.548 | -0.007 | -1.3% | $0.557 | $0.582 | $0.54 | 24,970 | |
| $0.555 | -0.035 | -5.9% | $0.552 | $0.58 | $0.535 | 32,520 | |
| $0.59 | -0.03 | -4.8% | $0.591 | $0.601 | $0.56 | 78,950 | |
| $0.62 | -0.034 | -5.2% | $0.642 | $0.645 | $0.601 | 106,910 | |
| $0.654 | +0.057 | +9.5% | $0.62 | $0.857 | $0.60 | 4,689,860 | |
| $0.597 | -0.064 | -9.7% | $0.66 | $0.66 | $0.58 | 60,690 | |
| $0.661 | -0.012 | -1.8% | $0.674 | $0.686 | $0.623 | 52,000 | |
| $0.673 | -0.061 | -8.3% | $0.72 | $0.73 | $0.67 | 50,330 | |
| $0.734 | -0.01 | -1.3% | $0.738 | $0.75 | $0.713 | 40,940 | |
| $0.744 | -0.038 | -4.9% | $0.78 | $0.78 | $0.704 | 88,170 | |
| $0.782 | -0.038 | -4.6% | $0.758 | $0.87 | $0.75 | 90,520 | |
| $0.82 | -0.29 | -26.1% | $1.05 | $1.07 | $0.72 | 547,260 | |
| $1.11 | +0.08 | +7.8% | $1.19 | $1.36 | $1.05 | 2,256,990 | |
| $1.03 | +0.119 | +13.1% | $1.12 | $1.42 | $1.00 | 4,778,540 | |
| $0.911 | +0.001 | +0.1% | $0.83 | $0.92 | $0.78 | 579,460 | |
| $0.91 | +0.227 | +33.2% | $0.655 | $1.15 | $0.655 | 3,196,410 | |
| $0.683 | +0.028 | +4.3% | $0.644 | $0.70 | $0.644 | 16,540 | |
| $0.655 | +0.016 | +2.5% | $0.643 | $0.669 | $0.634 | 13,390 | |
| $0.639 | -0.025 | -3.8% | $0.67 | $0.68 | $0.639 | 17,130 | |
| $0.664 | +0.001 | +0.2% | $0.66 | $0.674 | $0.65 | 10,250 | |
| $0.663 | +0.018 | +2.8% | $0.639 | $0.69 | $0.639 | 12,280 | |
| $0.645 | +0.008 | +1.3% | $0.649 | $0.678 | $0.586 | 61,240 | |
| $0.637 | -0.119 | -15.7% | $0.764 | $0.778 | $0.637 | 55,360 | |
| $0.756 | -0.026 | -3.3% | $0.79 | $0.79 | $0.744 | 16,550 | |
| $0.782 | -0.031 | -3.8% | $0.819 | $0.844 | $0.767 | 17,290 | |
| $0.813 | -0.027 | -3.2% | $0.835 | $0.835 | $0.801 | 26,290 | |
| $0.84 | -0.18 | -17.6% | $0.861 | $0.95 | $0.82 | 126,200 | |
| $1.02 | +0.281 | +38.0% | $0.739 | $1.05 | $0.711 | 666,330 | |
| $0.739 | +0.065 | +9.6% | $0.682 | $0.745 | $0.66 | 28,830 | |
| $0.674 | +0.021 | +3.2% | $0.62 | $0.703 | $0.62 | 9,810 | |
| $0.653 | +0.026 | +4.1% | $0.619 | $0.69 | $0.619 | 12,670 | |
| $0.627 | +0.015 | +2.5% | $0.60 | $0.64 | $0.587 | 15,360 | |
| $0.612 | -0.02 | -3.2% | $0.628 | $0.644 | $0.61 | 8,770 | |
| $0.632 | -0.009 | -1.4% | $0.65 | $0.65 | $0.632 | 9,540 | |
| $0.641 | -0.002 | -0.3% | $0.645 | $0.656 | $0.64 | 7,720 | |
| $0.643 | -0.013 | -2.0% | $0.64 | $0.66 | $0.64 | 10,480 | |
| $0.656 | +0.005 | +0.8% | $0.65 | $0.657 | $0.633 | 35,330 | |
| $0.651 | -0.016 | -2.4% | $0.651 | $0.666 | $0.621 | 22,320 | |
| $0.667 | -0.044 | -6.2% | $0.69 | $0.71 | $0.66 | 23,120 |
Splits
4 splits since 2024 · NASDAQ:ONCO · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-10 | Consolidation | |
| 1-for-5 | Consolidation | |
| 1-for-85 | Consolidation | |
| 1-for-40 | Consolidation |
- Ticker
- NASDAQ:ONCO
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news
Onconetix Acquisition Target Realbotix Launches Echo Humanoid Robot Line with Tabletop and Full Body Models Designed for Education, Wellness, and Social Engagement
Oct 27, 2026
Closed $0.475 (+19.0%) on Oct 27, 2026
Onconetix Announces Reverse Stock Split
Oct 26, 2026
Closed $0.475 (+19.0%) on Oct 27, 2026
Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition
Oct 23, 2026
Closed $0.418 (+2.7%) on Oct 23, 2026
OncoC4 Receives FDA Fast Track Designation for Cesalatamig, an Investigational PD-1/VEGF Bispecific Antibody
Sep 16, 2026
Closed $0.663 (+2.8%) on Sep 16, 2026
CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition
Sep 14, 2026
Closed $0.637 (-15.7%) on Sep 14, 2026
Onco360® Has Been Selected as Part of an Ultra-Narrow Specialty Pharmacy Network for MIMRYLO™ (rusfertide)
Sep 9, 2026
Closed $0.813 (-3.2%) on Sep 9, 2026
Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events
Sep 3, 2026
Closed $0.739 (+9.6%) on Sep 3, 2026
OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for the Treatment of Advanced Solid Tumors
Aug 17, 2026
Closed $0.758 (-6.5%) on Aug 17, 2026
Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series
Aug 6, 2026
Closed $0.904 (-10.0%) on Aug 6, 2026
Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG
Aug 5, 2026
Closed $1.01 (+20.4%) on Aug 5, 2026
Onconetix, Inc. on 6ix
- News releases
- 23 in the last 12 months · 93 in all · newest Oct 27, 2026 · oldest 2022
Where Onconetix, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ONCO · Home listing · This page | NASDAQ | United States | USD |
| BOATS:ONCO | BOATS | United States | USD |
| Stuttgart:J4T0 | Stuttgart | Germany | EUR |
| gettex:A426MU | gettex | Germany | EUR |
| Frankfurt:J4T | Frankfurt | Germany | EUR |
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- −$370,091 USD
- P/E
- Loss
- EV/sales
- −0.8×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- Negative equity
- Gross margin
- 73.8%
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- Negative equity
- Beta vs S&P 500
- 0.80
Team and board
Officers
| Officer | Role |
|---|---|
| David Allan White | Chief Executive Officer |
| Karina M. Fedasz | Interim Chief Financial Officer |
Board
| Director | Role |
|---|---|
| Andrew Oakley | Chairman of the Board |
| Sammy Dorf | Director |
| Sarah Romano | Director |
| Thomas Meier | Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 16, 2026 | −6.5% |
| Q2 2026 | Aug 13, 2026 | −9.1% |
| Q1 2026 | May 11, 2026 | +7.4% |
| Q4 2025 | Mar 12, 2026 | −13.1% |
| Q3 2025 | Nov 28, 2025 | +13.3% |
| Q2 2025 | Aug 29, 2025 | −2.3% |
| Q1 2025 | May 30, 2025 | 0.0% |
| Q4 2024 | Mar 6, 2025 | +0.9% |
| Q3 2024 | Nov 7, 2024 | +0.8% |
| Q2 2024 | Aug 12, 2024 | −4.3% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 20, 2024 · After close | −15.7% |
| Q4 2023 | Mar 7, 2024 | −6.7% |
| Q3 2023 | Nov 17, 2023 · After close | −2.6% |
| Q2 2023 | Aug 14, 2023 | 0.0% |
| Q1 2023 | May 12, 2023 · After close | 0.0% |
| Q4 2022 | Mar 9, 2023 | 0.0% |
| Q3 2022 | Nov 10, 2022 | 0.0% |
| Q2 2022 | Aug 15, 2022 | 0.0% |
| Q1 2022 | May 13, 2022 | 0.0% |
| Q4 2021 | Feb 23, 2022 | 0.0% |
IPO
Went public as Blue Water Vaccines Inc. Priced at US$9.00 a share. Final prospectus filed on Feb 23, 2022.
- Price
- US$9.00 a share
- Shares offered
- 2,222,222 shares of common stock
- Offering size
- US$20 million
- Listing
- BWV on the Nasdaq Capital Market
- Underwriter
- Boustead Securities, LLC
- Shares delivered
- On or about Feb 23, 2022
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Aug 23, 2021 |
| Filed publicly | Oct 8, 2021 |
| Amended 6 times | Newest Feb 8, 2022 |
| Declared effective by the SEC | Feb 11, 2022 |
| Shares registered with an exchange | Feb 17, 2022 |
| Final prospectus, with the price | Feb 23, 2022 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Feb 23, 2022 |
| CERT · Exchange's certificate of listing | Feb 17, 2022 |
| 8-A12B · Registration of shares for listing on an exchange | Feb 17, 2022 |
| EFFECT · Notice that a registration is effective | Feb 11, 2022 |
| CORRESP · Letter to the SEC | Feb 11, 2022 |
| CORRESP · Letter to the SEC | Feb 11, 2022 |
| S-1/A · Registration statement, amended | Feb 8, 2022 |
| FWP · Free writing prospectus | Jan 21, 2022 |
| FWP · Free writing prospectus | Jan 21, 2022 |
| S-1/A · Registration statement, amended | Jan 6, 2022 |
All 24 filings
| Filing | Filed |
|---|---|
| S-1/A · Registration statement, amended | Dec 29, 2021 |
| CORRESP · Letter to the SEC | Dec 13, 2021 |
| S-1/A · Registration statement, amended | Dec 13, 2021 |
| UPLOAD · Letter from the SEC | Dec 9, 2021 |
| CORRESP · Letter to the SEC | Nov 29, 2021 |
| S-1/A · Registration statement, amended | Nov 29, 2021 |
| UPLOAD · Letter from the SEC | Nov 18, 2021 |
| S-1/A · Registration statement, amended | Nov 5, 2021 |
| CORRESP · Letter to the SEC | Nov 4, 2021 |
| UPLOAD · Letter from the SEC | Oct 21, 2021 |
| CORRESP · Letter to the SEC | Oct 8, 2021 |
| S-1 · Registration statement | Oct 8, 2021 |
| UPLOAD · Letter from the SEC | Sep 17, 2021 |
| DRS · Draft registration statement | Aug 23, 2021 |
Open IPO · From the cover of the final prospectus (424B4) filed Feb 23, 2022
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 815.4K | 2.52M | 58.5K | 0 | 0 | 0 | |
| Cost of revenue | 182.5K | 1.47M | 1.19M | 6.75K | 4.89K | 3.06K | 573 |
| Gross profit | 632.9K | 1.06M | -1.13M | -6.75K | -4.89K | -3.06K | -573 |
| Research and development | 66.1K | 154.4K | 1.95M | 4.13M | 1.33M | 524.9K | 60.2K |
| Selling, general and administrative | 7.04M | 11.2M | 14.8M | 9.35M | 2.09M | 1.10M | |
| Operating income | -17.9M | -56.5M | -36.0M | -13.5M | -3.42M | -1.62M | -880.2K |
| Depreciation and amortization | 15.2K | 731.3K | 43.9K | 6.75K | 4.89K | 3.06K | 573 |
| EBITDA | -17.8M | -55.8M | -36.0M | -13.5M | -3.41M | -1.62M | -879.7K |
| Interest expense | 751.0K | 873.4K | 671.6K | 0 | |||
| Income before tax | -14.0M | -59.7M | -37.4M | -13.4M | -3.42M | -1.60M | -821.9K |
| Income tax | 525 | -1.05M | -12.6K | 3.16T | 675.7B | -203.2K | -3 |
| Net income | -14.0M | -58.7M | -37.4M | -13.4M | -3.42M | -1.60M | -821.9K |
| Earnings per share, basic | -16.56 | -1,823.39 | -87.45 | -1.10 | -1.26 | -140.65 | -72.28 |
| Earnings per share, diluted | -16.56 | -1,823.39 | -87.45 | -1.10 | -1.26 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 5.22M | 646.5K | 4.55M | 25.8M | 1.93M | 4.31M | 6.05M |
| Receivables | 296.9K | 25.7K | 149.7K | 35.9K | 152.5K | 44.8K | 8.33K |
| Inventory | 150.0K | 64.1K | 364.1K | 0 | 757.6K | -35.0K | |
| Current assets | 6.07M | 950.3K | 5.84M | 26.3M | 3.07M | 4.60M | 6.06M |
| Property, plant and equipment | 37.1K | 62.9K | 60.7K | 14.1K | 11.5K | ||
| Goodwill | 18.5M | 18.5M | 55.7M | 0 | |||
| Total assets | 24.9M | 28.2M | 87.5M | 26.3M | 3.08M | 4.81M | 6.08M |
| Accounts payable | 1.76M | 3.79M | 5.30M | 1.50M | 582.6K | 68.7K | 18.4K |
| Current liabilities | 9.14M | 18.3M | 17.2M | 3.92M | 1.64M | 68.7K | 75.8K |
| Long-term debt | 118.9K | ||||||
| Total debt | 48.8K | 9.45M | 9.89M | ||||
| Total liabilities | 9.16M | 18.6M | 21.9M | 3.92M | 1.64M | 78.3K | 82.6K |
| Shareholders' equity | 15.8M | 8.54M | -5.60M | 22.4M | 1.45M | 4.73M | 6.00M |
| Shares outstanding | 31.2K | 138.3K | 558.1K | 15.3M | 3.20M | 11.4K | 11.4K |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -9.68M | -10.5M | -13.6M | -8.68M | -2.04M | -1.73M | -825.1K |
| Capital spending | 0 | -28.5K | -3.30K | -9.34K | -1.92K | -11.8K | -4.50K |
| Free cash flow | -9.68M | -10.5M | -13.6M | -8.68M | -2.05M | -1.74M | -829.6K |
| Cash from investing | -28.5K | -8.65M | -32.7K | -1.92K | -11.8K | -4.50K | |
| Cash from financing | 14.5M | 6.74M | 1.04M | 32.5M | -334.2K | 0 | 6.88M |
| Dividends paid | -409.5K | -206.4K | |||||
| Share buybacks | -1.71M | -718 | -59.0K | -566.8K | 0 | ||
| Change in cash | 4.57M | -3.91M | -21.2M | 23.8M | -2.38M | -1.74M | 6.05M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Nov 16, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 12, 2026 | Meeting outcome | SEC |
| 8-K · Current report | Nov 9, 2026 | Current report | SEC |
| 425 | Nov 5, 2026 | Other filings | SEC |
| 8-K · Current report | Nov 5, 2026 | Material contract | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 5, 2026 | Big-stake notice | SEC |
| 425 | Oct 27, 2026 | Other filings | SEC |
| 8-K · Current report | Oct 26, 2026 | Current report | SEC |
| DEFA14A · Additional proxy material | Oct 23, 2026 | Meeting notice | SEC |
| 8-K · Current report | Oct 23, 2026 | Current report | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 425 | Oct 23, 2026 | Other filings | SEC |
| ARS · Annual report to shareholders | Oct 16, 2026 | Annual report | SEC |
| DEF 14A · Proxy statement | Oct 7, 2026 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Sep 17, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Sep 14, 2026 | Meeting notice | SEC |
| 8-K · Current report | Sep 14, 2026 | Material contract | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| 424B3 · Prospectus | Sep 8, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Sep 4, 2026 | Other filings | SEC |
| 425 | Sep 3, 2026 | Other filings | SEC |
| S-1/A · Registration statement, amended | Aug 31, 2026 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 13, 2026 | Quarterly report | SEC |
| S-1 · Registration statement | Aug 12, 2026 | Offer document | SEC |
| 425 | Aug 6, 2026 | Other filings | SEC |
| 8-K · Current report | Jul 29, 2026 | Material contract | SEC |
| SCHEDULE 13G · Big-stake notice | Jul 27, 2026 | Big-stake notice | SEC |
| 425 | Jul 7, 2026 | Other filings | SEC |
| 425 | Jun 24, 2026 | Other filings | SEC |
| 424B3 · Prospectus | Jun 17, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jun 17, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 15, 2026 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jun 12, 2026 | Other filings | SEC |
| S-1 · Registration statement | Jun 8, 2026 | Offer document | SEC |
| 8-K · Current report | May 19, 2026 | Current report | SEC |
| 8-K · Current report | May 13, 2026 | Current report | SEC |
| 10-Q · Quarterly report | May 13, 2026 | Quarterly report | SEC |
| EFFECT · Notice that a registration is effective | May 12, 2026 | Other filings | SEC |
| 424B3 · Prospectus | May 11, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | May 8, 2026 | Other filings | SEC |
| S-1/A · Registration statement, amended | May 7, 2026 | Offer document | SEC |
| CORRESP · Letter to the SEC | May 7, 2026 | Other filings | SEC |
| POS AM · Amendment to an effective registration | May 6, 2026 | Offer document | SEC |
| UPLOAD · Letter from the SEC | May 5, 2026 | Other filings | SEC |
| 8-K · Current report | May 4, 2026 | Meeting outcome | SEC |
| S-1 · Registration statement | Apr 28, 2026 | Offer document | SEC |
| 8-K · Current report | Apr 24, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Apr 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 16, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Apr 16, 2026 | Insider trade | SEC |
| 425 | Apr 9, 2026 | Other filings | SEC |
| 425 | Apr 2, 2026 | Other filings | SEC |
| 425 | Mar 31, 2026 | Other filings | SEC |
| DEF 14A · Proxy statement | Mar 30, 2026 | Meeting notice | SEC |
| 3 · Initial statement of ownership | Mar 27, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 27, 2026 | Insider trade | SEC |
| 8-K · Current report | Mar 26, 2026 | Current report | SEC |
| 425 | Mar 25, 2026 | Other filings | SEC |
| 8-K/A · Current report, amended | Mar 25, 2026 | Management or board change | SEC |
| 8-K · Current report | Mar 24, 2026 | Management or board change | SEC |
| PRE 14A · Preliminary proxy statement | Mar 18, 2026 | Meeting notice | SEC |
| 10-K · Annual report | Mar 13, 2026 | Annual report | SEC |
| 425 | Feb 12, 2026 | Other filings | SEC |
| 8-K · Current report | Feb 12, 2026 | Material contract | SEC |
| 8-K · Current report | Feb 9, 2026 | Meeting outcome | SEC |
| DEF 14A · Proxy statement | Jan 2, 2026 | Meeting notice | SEC |
| EFFECT · Notice that a registration is effective | Dec 29, 2025 | Other filings | SEC |
| 424B3 · Prospectus | Dec 23, 2025 | Offer document | SEC |
| CORRESP · Letter to the SEC | Dec 22, 2025 | Other filings | SEC |
| PRE 14A · Preliminary proxy statement | Dec 22, 2025 | Meeting notice | SEC |
| S-1/A · Registration statement, amended | Dec 19, 2025 | Offer document | SEC |
| 3 · Initial statement of ownership | Dec 12, 2025 | Insider trade | SEC |
| 8-K · Current report | Dec 10, 2025 | Management or board change | SEC |
| 8-K · Current report | Dec 10, 2025 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 13, 2025 | Quarterly report | SEC |
| 424B3 · Prospectus | Nov 10, 2025 | Offer document | SEC |
| DEF 14A · Proxy statement | Nov 10, 2025 | Meeting notice | SEC |
| S-1 · Registration statement | Nov 4, 2025 | Offer document | SEC |
| 8-K · Current report | Oct 29, 2025 | Current report | SEC |
| PRE 14A · Preliminary proxy statement | Oct 28, 2025 | Meeting notice | SEC |
| S-1 · Registration statement | Oct 15, 2025 | Offer document | SEC |
| D | Oct 7, 2025 | Other filings | SEC |
| 8-K · Current report | Oct 3, 2025 | Material contract | SEC |
| 8-K · Current report | Sep 26, 2025 | Material contract | SEC |
| 8-K · Current report | Sep 22, 2025 | Material contract | SEC |
| 8-K · Current report | Sep 4, 2025 | Material contract | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 12, 2025 | Material contract | SEC |
| 4 · Change in ownership | Jul 16, 2025 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Jul 16, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Jul 16, 2025 | Material contract | SEC |
| 8-K · Current report | Jun 16, 2025 | Current report | SEC |
| 10-Q · Quarterly report | Jun 12, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jun 11, 2025 | Material contract | SEC |
| 8-K · Current report | Jun 5, 2025 | Meeting outcome | SEC |
| 10-K · Annual report | Jun 2, 2025 | Annual report | SEC |
| 8-K · Current report | May 22, 2025 | Material contract | SEC |
| UPLOAD · Letter from the SEC | May 2, 2025 | Other filings | SEC |
| 8-K · Current report | Apr 30, 2025 | Current report | SEC |
| DEF 14A · Proxy statement | Apr 29, 2025 | Meeting notice | SEC |
| PRER14A | Apr 28, 2025 | Other filings | SEC |
| PRE 14A · Preliminary proxy statement | Apr 18, 2025 | Meeting notice | SEC |
| 8-K · Current report | Apr 18, 2025 | Current report | SEC |
| 8-K · Current report | Apr 8, 2025 | Current report | SEC |
| 8-K · Current report | Apr 3, 2025 | Management or board change | SEC |
| NT 10-K · Late filing notice | Apr 1, 2025 | Explanation request | SEC |
| 4 · Change in ownership | Mar 25, 2025 | Insider trade | SEC |
| 8-K · Current report | Mar 24, 2025 | Current report | SEC |
| 8-K · Current report | Mar 19, 2025 | Current report | SEC |
| 3 · Initial statement of ownership | Mar 7, 2025 | Insider trade | SEC |
| 8-K · Current report | Feb 28, 2025 | Material contract | SEC |
| 8-K · Current report | Feb 18, 2025 | Material contract | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 13, 2025 | Big-stake notice | SEC |
| 424B3 · Prospectus | Feb 12, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Feb 12, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Feb 10, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | Feb 7, 2025 | Offer document | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 7, 2025 | Big-stake notice | SEC |
| UPLOAD · Letter from the SEC | Feb 3, 2025 | Other filings | SEC |
| S-1 · Registration statement | Jan 27, 2025 | Offer document | SEC |
| 8-K · Current report | Jan 24, 2025 | Current report | SEC |
| 8-K · Current report | Jan 22, 2025 | Current report | SEC |
| 4 · Change in ownership | Jan 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 22, 2025 | Insider trade | SEC |
| 424B3 · Prospectus | Dec 17, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Dec 13, 2024 | Other filings | SEC |
| 8-K · Current report | Dec 12, 2024 | Current report | SEC |
| CORRESP · Letter to the SEC | Dec 11, 2024 | Other filings | SEC |
| S-1/A · Registration statement, amended | Dec 11, 2024 | Offer document | SEC |
| S-8 · Registration statement for employee plans | Dec 11, 2024 | Offer document | SEC |
| S-1/A · Registration statement, amended | Dec 10, 2024 | Offer document | SEC |
| 10-Q · Quarterly report | Dec 9, 2024 | Quarterly report | SEC |
| 8-K · Current report | Dec 3, 2024 | Material contract | SEC |
| NT 10-Q · Late filing notice | Nov 15, 2024 | Explanation request | SEC |
| 424B4 · Prospectus | Nov 15, 2024 | Offer document | SEC |
| SC 13G · Big-stake notice | Nov 14, 2024 | Big-stake notice | SEC |
| EFFECT · Notice that a registration is effective | Nov 13, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Nov 12, 2024 | Other filings | SEC |
| S-1/A · Registration statement, amended | Nov 12, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Nov 12, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Nov 12, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Nov 12, 2024 | Other filings | SEC |
| S-1/A · Registration statement, amended | Nov 12, 2024 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Nov 7, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Nov 7, 2024 | Other filings | SEC |
| S-1 · Registration statement | Nov 1, 2024 | Offer document | SEC |
| S-1 · Registration statement | Nov 1, 2024 | Offer document | SEC |
| 3/A · Initial statement of ownership, amended | Nov 1, 2024 | Insider trade | SEC |
| DEF 14C | Oct 31, 2024 | Meeting notice | SEC |
| 8-K · Current report | Oct 21, 2024 | Current report | SEC |
| PRE 14C | Oct 18, 2024 | Meeting notice | SEC |
| D | Oct 17, 2024 | Other filings | SEC |
| 8-K/A · Current report, amended | Oct 9, 2024 | Financing | SEC |
| 8-K · Current report | Oct 3, 2024 | Material contract | SEC |
| SC 13D · Big-stake notice | Oct 1, 2024 | Big-stake notice | SEC |
| SC 13D · Big-stake notice | Oct 1, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 30, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2024 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Sep 27, 2024 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Sep 26, 2024 | Insider trade | SEC |
| SC 13D · Big-stake notice | Sep 26, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 26, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 26, 2024 | Insider trade | SEC |
| SC 13G · Big-stake notice | Sep 26, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Sep 24, 2024 | Financing | SEC |
| 8-K · Current report | Sep 20, 2024 | Material contract | SEC |
| 8-K · Current report | Sep 20, 2024 | Current report | SEC |
| 8-K · Current report | Sep 10, 2024 | Meeting outcome | SEC |
| 8-K · Current report | Sep 4, 2024 | Current report | SEC |
| DEFA14A · Additional proxy material | Sep 3, 2024 | Meeting notice | SEC |
| 8-K · Current report | Sep 3, 2024 | Current report | SEC |
| 10-Q · Quarterly report | Aug 29, 2024 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Aug 14, 2024 | Explanation request | SEC |
| 8-K · Current report | Aug 7, 2024 | Current report | SEC |
| DEF 14A · Proxy statement | Aug 1, 2024 | Meeting notice | SEC |
| PRER14A | Jul 22, 2024 | Other filings | SEC |
| 8-K · Current report | Jul 15, 2024 | Current report | SEC |
| 8-K · Current report | Jul 11, 2024 | Material contract | SEC |
| 424B4 · Prospectus | Jul 3, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jul 2, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 28, 2024 | Other filings | SEC |
| S-1/A · Registration statement, amended | Jun 24, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Jun 24, 2024 | Other filings | SEC |
| PRER14A | Jun 24, 2024 | Other filings | SEC |
| 3 · Initial statement of ownership | Jun 20, 2024 | Insider trade | SEC |
| 8-K/A · Current report, amended | Jun 14, 2024 | Management or board change | SEC |
| UPLOAD · Letter from the SEC | Jun 14, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 13, 2024 | Other filings | SEC |
| 8-K · Current report | Jun 13, 2024 | Management or board change | SEC |
| SC 13G/A · Big-stake notice, amended | Jun 10, 2024 | Big-stake notice | SEC |
| S-1/A · Registration statement, amended | Jun 4, 2024 | Offer document | SEC |
This page holds 200 of 401 filings. Open Filings
Cap table
Built by 6ix from Onconetix, Inc.’s releases · as of Nov 10, 2026
- Common shares
- 820,611
- Fully diluted
- 820,611
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 820,611 | Nov 10, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 10, 2026 | 820,611 |
| Oct 26, 2026 | |
| May 19, 2026 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James Sapirstein Other companies: INmune Bio Inc. (Director · Since at least Sep 8, 2026); Cocrystal Pharma, Inc. (Chief Executive Officer · Since at least Jun 3, 2026); ZyVersa Therapeutics, Inc. (Director · Since at least Jan 5, 2023); Blue Water Acquisition Corp (Director · Dec 15, 2020 – Dec 15, 2020 · Past); Marizyme, Inc. (Interim CEO, Director · Sep 10, 2020 – Mar 5, 2021 · Past); GridAI Technologies Corp. (Chairman and CEO, Director · Oct 8, 2019 – Jul 2, 2024 · Past); Lunai Bioworks Inc. (Director · Mar 6, 2018 – Jun 25, 2024 · Past); Hepion Pharmaceuticals, Inc. (Chief Executive Officer, Director · Jan 3, 2018 – Jan 3, 2018 · Past); RespireRx Pharmaceuticals Inc (Director · Dec 9, 2017 – Dec 9, 2017 · Past) | Director · Feb 23, 2022 – Sep 26, 2024 · Past |
| Bruce Harmon Other companies: Idaho Copper Corporation (Chief Financial Officer · Since at least Jul 28, 2026); Marizyme, Inc. (CFO · Sep 1, 2020 – Oct 22, 2020 · Past); Green Innovations Ltd (Director · May 16, 2013 – Dec 31, 2014 · Past) | Chief Financial Officer · Oct 4, 2023 – Oct 4, 2023 · Past |
| Joseph Hernandez Other companies: Blue Water Acquisition Corp. IV (Chief Executive Officer, Director · Since at least Mar 19, 2026); Blue Water Acquisition Corp. III (Chief Executive Officer, Director · Since at least Jun 9, 2025); Clarus Therapeutics Holdings Inc (Director · Apr 25, 2022 – Jun 7, 2022 · Past) | CEO, Director · May 4, 2022 – May 9, 2023 · Past |
| Kimberly M Murphy Other companies: Clarus Therapeutics Holdings Inc (Director · Dec 12, 2021 – Jun 7, 2022 · Past); Blue Water Acquisition Corp (Director · Dec 14, 2020 – Dec 14, 2020 · Past); Oragenics Inc. (Director · May 1, 2020 – Sep 19, 2024 · Past) | Director · Feb 17, 2022 – May 4, 2022 · Past |
| Sarah Romano Other companies: SS Innovations International Inc. (CFO · Since at least Jul 15, 2026); Vicarious Surgical, Inc. (Chief Financial Officer · Since at least Apr 1, 2025); GridAI Technologies Corp. (Chief Financial Officer · Jan 3, 2023 – Jan 6, 2025 · Past) | Director · Since at least Dec 5, 2025 |
| Allan Shaw Other companies: CalciMedica, Inc. (Director · Since at least Mar 20, 2023); VIVUS Inc (Director · Oct 15, 2017 – Oct 26, 2018 · Past) | Director · Feb 17, 2022 – Aug 19, 2022 · Past |
| Timothy R Ramdeen Other companies: Tribeca Strategic Acquisition Corp. (Chairman, CEO, Director · Since at least May 28, 2026); GridAI Technologies Corp. (Director · Aug 9, 2024 – Aug 9, 2024 · Past) | Director · Since at least Jan 13, 2023 |
| Vuk Jeremić Other companies: Skyline Builders Group Holding Limited (Director · Since at least Mar 31, 2026); Aureus Greenway Holdings Inc. (Director · Since at least Sep 9, 2025) | Director · Nov 4, 2022 – May 31, 2023 · Past |
| Andrew Oakley Other companies: Tribeca Strategic Acquisition Corp. (Director · Since at least May 28, 2026) | Chairman of the Board · Since at least Feb 24, 2025 |
| David White Other companies: Realbotix Corp (Chief Executive Officer · Mar 31, 2026 – Nov 4, 2026 · Past) | Chief Executive Officer · Since at least Mar 31, 2026 |
All 17 people
| Person | Seat |
|---|---|
| Karina M. Fedasz Other companies: IDW Media Holdings, Inc. (CFO, Treasurer & Corporate Sec · Jul 1, 2021 – Jul 1, 2021 · Past) | Interim Chief Financial Officer · Since at least Jun 10, 2024 |
| Simon Tarsh Other companies: Lunai Bioworks Inc. (Interim CFO · Mar 11, 2024 – Nov 4, 2024 · Past) | Director · Since at least Aug 22, 2022 |
| Christian Bruhlmann | Chief Strategy Officer · Dec 15, 2023 – Dec 20, 2024 · Past |
| Neil J Campbell | Chief Executive Officer, Director · Oct 4, 2023 – Oct 4, 2023 · Past |
| Ralph Schiess | Interim CEO, CSO · Dec 15, 2023 – Dec 20, 2024 · Past |
| Sammy Dorf | Director · Since at least Mar 31, 2026 |
| Thomas Meier | Director · Since at least Feb 6, 2024 |
Log in to ask 6ix AI your own questions about Onconetix, Inc.